Clinical Trials Directory

Trials / Completed

CompletedNCT04291846

A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects

A Randomized, Open, Single-center, Two-cycle, Double-sequence Crossover Study to Investigate the Effects of a High-fat Diet on the Pharmacokinetics of Healthy Chinese Adult Subjects After Oral Administration of SHR1459 Tablets

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Jiangsu HengRui Medicine Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary objective of the study is to evaluate the effect of high-fat diet on pharmacokinetics of healthy Chinese adult subjects after oral administration of SHR1459 tablets. The secondary objective of the study is to evaluate the safety of single dose of SHR1459 orally in healthy subjects.

Conditions

Interventions

TypeNameDescription
DRUGSHR1459 fasted in P1, high-fat diet in P2SHR1459 administration in fasted condition in period 1, SHR1459 administration after high-fat diet in period 2
DRUGSHR1459 high-fat diet in P1, fasted in P2SHR1459 administration after high-fat diet in period 1, SHR1459 administration in fasted condition in period 2

Timeline

Start date
2020-05-24
Primary completion
2020-06-03
Completion
2020-06-29
First posted
2020-03-02
Last updated
2020-07-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04291846. Inclusion in this directory is not an endorsement.